Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer
Clinical trial NCT06105684 · RECRUITING
Trial details
- NCT number
- NCT06105684
- Sponsor
- University of Alabama at Birmingham
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-14
- Primary completion
- 2028-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.